SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000936392-08-000494
Filing Date
2008-08-05
Accepted
2008-08-04 17:51:19
Documents
2
Effectiveness Date
2008-08-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS FILED BY NON REGISTRANT a42709dfan14a.htm DFAN14A 17616
2 GRAPHIC a42709a4270901.gif GRAPHIC 3245
  Complete submission text file 0000936392-08-000494.txt   24312
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address 10505 ROSELLE STREET SAN DIEGO CA 92121 858-558-4850
SGX PHARMACEUTICALS, INC. (Subject) CIK: 0001125603 (see all company filings)

IRS No.: 061523147 | State of Incorp.: DE
Type: DFAN14A | Act: 34 | File No.: 000-51745 | Film No.: 08989094
SIC: 2834 Pharmaceutical Preparations